Undetected isoniazid resistance leads to rifampin-resistant tuberculosis
This prospective study in Vietnam demonstrates that undetected isoniazid resistance in rifampin-susceptible tuberculosis patients drastically increases the risk of acquiring rifampin resistance by approximately 100-fold, suggesting that routine isoniazid susceptibility testing could significantly reduce the future burden of rifampin-resistant TB.